These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15093601)

  • 41. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
    Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological evaluation of membrane-moderated transdermal system of glipizide.
    Mutalik S; Udupa N
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):17-26. PubMed ID: 16445694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs.
    Prabakaran D; Singh P; Jaganathan KS; Vyas SP
    J Control Release; 2004 Mar; 95(2):239-48. PubMed ID: 14980772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extrudable core system: development of a single-layer osmotic controlled-release tablet.
    Waterman KC; MacDonald BC; Roy MC
    J Control Release; 2009 Mar; 134(3):201-6. PubMed ID: 19100796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug.
    Philip A; Pathak K
    PDA J Pharm Sci Technol; 2007; 61(1):24-36. PubMed ID: 17390701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and evaluation of mucoadhesive beads of glipizide as a controlled release drug delivery system.
    Bera K; Khanam J; Mohanraj KP; Mazumder B
    J Microencapsul; 2014; 31(3):220-9. PubMed ID: 24047213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system.
    Kumar A; Philip AK; Pathak K
    Curr Drug Deliv; 2011 Sep; 8(5):474-82. PubMed ID: 21696358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation.
    El-Gibaly I; Abdel-Ghaffar SK
    Int J Pharm; 2005 Apr; 294(1-2):33-51. PubMed ID: 15814229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastroretentive drug delivery system of Ranitidine hydrochloride based on osmotic technology: development and evaluation.
    Kumar P; Singh S; Mishra B
    Curr Drug Deliv; 2008 Oct; 5(4):332-42. PubMed ID: 18855605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique.
    Garcia J; Ghaly ES
    Pharm Dev Technol; 2001 Aug; 6(3):407-17. PubMed ID: 11485182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin.
    Kanagale P; Lohray BB; Misra A; Davadra P; Kini R
    AAPS PharmSciTech; 2007 Jul; 8(3):E53. PubMed ID: 17915803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osmotically controlled oral delivery of ciprofloxacin through asymmetric membrane capsules.
    Suman M; Chauhan DK; Reddy N
    Pharmazie; 2012 Aug; 67(8):687-94. PubMed ID: 22957433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
    Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y
    Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Situ Phase-Transited Asymmetric Membrane Capsules: A Means for Achieving Delayed and Osmotic Release for pH Solubility-Dependant Drugs.
    Philip AK; Philip B
    PDA J Pharm Sci Technol; 2011; 65(1):32-41. PubMed ID: 21414938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assemblage of novel release modules for the development of adaptable drug delivery systems.
    Losi E; Bettini R; Santi P; Sonvico F; Colombo G; Lofthus K; Colombo P; Peppas NA
    J Control Release; 2006 Mar; 111(1-2):212-8. PubMed ID: 16458384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
    Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.